Burn J, Dennis M, Bamford J, Sandercock P, Wade D, Warlow C. Long-term risk of recurrent stroke after a first-ever stroke. The Oxfordshire Community Stroke Project. Stroke. 1994;25(2):333–7.
Article CAS PubMed Google Scholar
Lee M, Wu YL, Ovbiagele B. Trends in incident and recurrent rates of first-ever ischemic stroke in Taiwan between 2000 and 2011. J Stroke. 2016;18(1):60–5.
Samsa GP, Bian J, Lipscomb J, Matchar DB. Epidemiology of recurrent cerebral infarction: a medicare claims-based comparison of first and recurrent strokes on 2-year survival and cost. Stroke. 1999;30(2):338–49.
Article CAS PubMed Google Scholar
Ozkan H, Ambler G, Banerjee G, et al. Prevalence, patterns, and predictors of patient-reported non-motor outcomes at 30 days after acute stroke: prospective observational hospital cohort study. Int J Stroke. 2023. https://doi.org/10.1177/17474930231215660.
Article PubMed PubMed Central Google Scholar
Kim J, Olaiya MT, De Silva DA, et al. Global stroke statistics 2023: availability of reperfusion services around the world. Int J Stroke. 2024. https://doi.org/10.1177/17474930231210448.
Article PubMed PubMed Central Google Scholar
Edwards JD, Dominguez-Vargas AU, Rosso C, et al. A translational roadmap for transcranial magnetic and direct current stimulation in stroke rehabilitation: consensus-based core recommendations from the third stroke recovery and rehabilitation roundtable. Int J Stroke. 2023. https://doi.org/10.1177/17474930231203982.
Article PubMed PubMed Central Google Scholar
Downer MB, Luengo-Fernandez R, Binney LE, et al. Association of multimorbidity with mortality after stroke stratified by age, severity, etiology, and prior disability. Int J Stroke. 2023. https://doi.org/10.1177/17474930231210397.
Article PubMed PubMed Central Google Scholar
Alvarado-Bolaños A, Ayan D, Khaw AV, et al. Differences in stroke recurrence risk between atrial fibrillation detected on ECG and 14-day cardiac monitoring. Stroke. 2023;54(8):2022–30.
Li W, Jin C, Vaidya A, et al. Blood pressure trajectories and the risk of intracerebral hemorrhage and cerebral infarction: a prospective study. Hypertension. 2017;70(3):508–14.
Article CAS PubMed Google Scholar
Kelly DM, Georgakis MK, Franceschini N, Blacker D, Viswanathan A, Anderson CD. Interplay between chronic kidney disease, hypertension, and stroke: insights from a multivariable Mendelian randomization analysis. Neurology. 2023;101(20):e1960–9.
Article CAS PubMed PubMed Central Google Scholar
Xu J, Xie Z, Chen K, et al. The L-shaped correlation between systolic blood pressure and short-term and long-term mortality in patients with cerebral hemorrhage. BMC Neurol. 2023;23(1):230.
Article PubMed PubMed Central Google Scholar
Acosta JN, Both CP, Demarais ZS, et al. Polygenic susceptibility to hypertension and blood pressure control in stroke survivors. Neurology. 2023;100(15):e1587–97.
Article CAS PubMed PubMed Central Google Scholar
Hawkes MA, Anderson CS, Rabinstein AA. Blood pressure variability after cerebrovascular events: a possible new therapeutic target: a narrative review. Neurology. 2022;99(4):150–60.
Alter M, Friday G, Lai SM, O’Connell J, Sobel E. Hypertension and risk of stroke recurrence. Stroke. 1994;25(8):1605–10.
Article CAS PubMed Google Scholar
Liu H, Jing J, Wang A, et al. Stroke recurrence and antiplatelets in posterior versus anterior circulation minor stroke or transient ischemic attack. Stroke. 2023;54(4):964–72.
Article CAS PubMed Google Scholar
Paciaroni M, Caso V, Agnelli G, et al. Recurrent ischemic stroke and bleeding in patients with atrial fibrillation who suffered an acute stroke while on treatment with nonvitamin K antagonist oral anticoagulants: the RENO-EXTEND study. Stroke. 2022;53(8):2620–7.
Article CAS PubMed Google Scholar
Peng Y, Ngo L, Hay K, Alghamry A, Colebourne K, Ranasinghe I. Long-term survival, stroke recurrence, and life expectancy after an acute stroke in Australia and New Zealand from 2008–2017: a population-wide cohort study. Stroke. 2022;53(8):2538–48.
Article CAS PubMed Google Scholar
McGurgan IJ, Kelly PJ, Turan TN, Rothwell PM. Long-term secondary prevention: management of blood pressure after a transient ischemic attack or stroke. Stroke. 2022;53(4):1085–103.
Hsieh MT, Liu CH, Lin SH, et al. Recurrent ischemic stroke and cardiovascular outcomes in patients with atrial fibrillation with ischemic stroke despite direct oral anticoagulants. Stroke. 2023;54(4):e145–6.
Liu L, Wang Z, Gong L, et al. Blood pressure reduction for the secondary prevention of stroke: a Chinese trial and a systematic review of the literature. Hypertens Res. 2009;32(11):1032–40.
Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6,105 individuals with previous stroke or transient ischaemic attack. PROGRESS Collaborative Group. Lancet 2001;358(9287):1033–41.
Schrader J, Lüders S, Kulschewski A, et al. Morbidity and mortality after stroke, eprosartan compared with nitrendipine for secondary prevention: principal results of a prospective randomized controlled study (MOSES). Stroke. 2005;36(6):1218–26.
Article CAS PubMed Google Scholar
Yusuf S, Diener HC, Sacco RL, et al. Telmisartan to prevent recurrent stroke and cardiovascular events. N Engl J Med. 2008;359(12):1225–37.
Article CAS PubMed PubMed Central Google Scholar
Kitagawa K, Yamamoto Y, Arima H, et al. Effect of standard vs intensive blood pressure control on the risk of recurrent stroke: a randomized clinical trial and meta-analysis. JAMA Neurol. 2019;76(11):1309–18.
Article PubMed PubMed Central Google Scholar
PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure–lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet. 2001;358(9287):1033–41.
Nissen SE, Tuzcu EM, Libby P, et al. CAMELOT Investigators. Effect of antihypertensive agents on cardiovascular events in patients with coronary disease and normal blood pressure: the CAMELOT study: a randomized controlled trial. JAMA. 2004;292(18):2217–25.
Article CAS PubMed Google Scholar
Hung WH, Sung J, Chen WY, et al. Risk of stroke with antivenom usage after venomous snakebite in Taiwan: a population-based cohort study. QJM Int J Med. 2022;115(9):587–95.
Kleindorfer DO, Towfighi A, Chaturvedi S, et al. 2021 guideline for the prevention of stroke in patients with stroke and transient ischemic attack: a guideline from the American Heart Association/American Stroke Association. Stroke. 2021;52(7):e364–467.
Katsanos AH, Filippatou A, Manios E, et al. Blood pressure reduction and secondary stroke prevention: a systematic review and metaregression analysis of randomized clinical trials. Hypertension. 2017;69(1):171–9.
Article CAS PubMed Google Scholar
Zonneveld TP, Richard E, Vergouwen MD, et al. Blood pressure-lowering treatment for preventing recurrent stroke, major vascular events, and dementia in patients with a history of stroke or transient ischaemic attack. Cochrane Database Syst Rev. 2018;7(7):Cd007858.
Boncoraglio GB, Del Giovane C, Tramacere I. Antihypertensive drugs for secondary prevention after ischemic stroke or transient ischemic attack: a systematic review and meta-analysis. Stroke. 2021;52(6):1974–82.
Article CAS PubMed Google Scholar
Messerli FH, Bangalore S, Bavishi C, Rimoldi SF. Angiotensin-converting enzyme inhibitors in hypertension: to use or not to use? J Am Coll Cardiol. 2018;71(13):1474–82.
Comments (0)